will cover current topics from recent developments in key areas of metabolism, diabetes and its complications.

This year’s conference will be focusing on various fields in diabetes research and related fields in the following four sessions:

Session I: Metabolic Control by Hormones and Metabolites

Session II: Epigenetics and Obesity

Session III: Classical and Novel Diabetic Complications

Session IV: Fasting and Therapeutic Concepts in Metabolic Dysfunction

The meeting begins with registration at 08:00 am on Wednesday, November 13th, and ends on Thursday, November 14th, late afternoon.

November, 13th, 08:00 - 17:00

November, 14th, 08:00 - 16:00

Scientific Program

Wednesday, November 13th

For a complete schedule of events, please download the program.

08.00 - 08.50 Registration
08.50 Welcome
Stephan Herzig, Helmholtz Center Munich, Institute for Diabetes and Cancer,
09.00 -12.30 Session I: Metabolic Control by Hormones and Metabolites
09.00 Talk 1
Endogenous aldehydes and human disease
Gerry Crossan, MRC Laboratory of Molecular Biology, Cambridge, UK
09.30 Talk 2
Thiosulfate sulfurtransferase in diabetes
Harry van Goor, University of Groningen, The Netherlands
10.00 Talk 3
Molecular mechanisms to re-wire the Glucocorticoid Receptor for
enhanced therapeutic benefit

Karolien de Bosscher, Ghent University, Belgium
10.30 Coffee break
11.00 Talk 4
Genomic crosstalk defines the hepatic glucocorticoid response
Henriette Uhlenhaut, TUM & Helmholtz Diabetes Center HDC, Germany
11.30 Talk 5
Circadian and glucocorticoid control of energy metabolism
David Ray, University of Oxford, UK
12.00 Talk 6
Pathophysiology of NAFLD and modulation by nuclear receptors
Bart Staels, University and Pasteur Institute of Lille, France
12.30 - 13.30 Lunch break and poster session - Posters are displayed in Foyer
13.30 - 17.00 Session II: Epigenetics and Obesity
13.30 Talk 7
Metabolic and Epigenetic Language of the Circadian Clock
Paolo Sassone-Corsi, University of California, USA
14.00 Talk 8
Corepressor-mediated epigenome alterations in type 2 diabetes and fatty liver disease
Eckardt Treuter, Karolinska Institute (KI), Sweden
14.30 Talk 9
The epigenetic basis linking diabetes to Cancer
Geno Shi, Harvard Medical School, USA
15.00 Coffee break
15.30 Talk 10
Healthy obesity - fact or fiction?
Matthias Blüher, University Leipzig, Germany
16.00 Talk 11
Adipose Tissue Dysfunction and its Impact on Systemic Carbohydrate and Lipid Metabolism
Philipp Scherer, University of Texas Southwestern Medical Center, USA
16.30 Talk 12
Adipose tissue plasticity and the regulation of systemic metabolism
Christian Wolfrum, ETH Zurich, Switzerland
17.00 End of Sessions


Thursday, November 14th

08.00 - 08.50 Registration
09.00 - 12.30 Session III: Classical and Novel Diabetic Complications
09.00 Talk 13
Lipid Metabolism and Diabetic Complications
Subramaniam Pennathur, University of Michigan, USA
09.30 Talk 14
Modeling diabetic associated kidney complications using human induced pluripotent stem cells
Rohit Kulkarni, Harvard Medical School, USA
10.00 Talk 15
Novel lipid mediators in retinopathy
Ingrid Fleming, Goethe University Frankfurt, Germany
10.30 Coffee break
11.00 Talk 16
Methylglyoxal stress: a novel connection between diabetes and cancer
Akella Bellahcène, University of Liège, Belgium
11.30 - 12.30 Short Talks (selected from abstracts)
11.30 Genome-wide analysis of a micro-RNA-network during skeletal muscle regeneration
Jan Krützfeldt,University Hospital of Zurich and University of Zurich, Switzerland
11.45 Cistromic reprogramming of the diurnal glucocorticoid hormone response by high fat diet
Fabiana Quagliarini, Institute for Diabetes and Obesity (IDO) Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich (HMGU) and German Center for DiabetesResearch (DZD), Munich, Germany
12.00 Effect of short-term treatment with Fluvastatin on insulin sensitivity and activity of brown adipose tissue
Matthias Johannes Betz, University Hospital Basel and University of Basel, Switzerland
12.15 Effect of GPR-10 gene disruption on energy and lipid homeostasis
Kristina Bardova, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
12.30 - 13.30 Lunch break and poster session
Posters are displayed in Foyer
13.30 -15.30 Session IV: Fasting and Therapeutic Concepts in Metabolic Dysfunction
13.30 Talk 17
Starving cells with sphingolipids
Aimee Edinger, University of California, Irvine, USA
14.00 Talk 18
Diabetic micro-vasculopathy in human vascular organoids
Dontscho Kerjaschki, Medical University Vienna, Austria
14.30 Talk 19
Fasting Mimicking Diet to Extend Healthy Aging and Preventing Diabetes
Roberta Buono, University of Southern California USC, USA
15.00 Talk 20
Novel morphinan-based compounds for beta cell protection and diabetes control
Eckhard Lammert, Heinrich-Heine-Universität Düsseldorf, Germany
15.30 End of Sessions
15.30 -16.00 Farewell Coffee break and poster session
Posters are displayed in Foyer


Subject to change without notice.